News & Views

Ali Pashazadeh, Treehill Partners CEO was part of a series of interviewees for Mari Serebrov's viewpoints poll right after the U.S. elections 2024...
Introducing a mechanism for patenting a new potential use for a drug technology for a period of time after publishing clinical trial data...
Ali Pashazadeh, Treehill’s CEO, contributes to an article in Mergermarket summarising current trends in the European immunology, inflammatory and autoimmune marketplaces...
It wouldn't be accurate to say that surgeon-turned-healthcare investment banker and consultant Dr. Ali Pashazadeh traded his scalpels for spreadsheets...

Subscribe to our mailings!

Thank You

Please choose your subscriptions:

Unsubscribe any time using the footer of our emails. For information about our privacy practices, please visit our privacy policy.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.